These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38781935)

  • 1. Transcription Factor ETV4 Activates AURKA to Promote PD-L1 Expression and Mediate Immune Escape in Lung Adenocarcinoma.
    Yang P; He S; Ye L; Weng H
    Int Arch Allergy Immunol; 2024; 185(9):910-920. PubMed ID: 38781935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
    Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
    Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3.
    Ye H; Yu W; Li Y; Bao X; Ni Y; Chen X; Sun Y; Chen A; Zhou W; Li J
    Hum Vaccin Immunother; 2023 Dec; 19(3):2269790. PubMed ID: 37877820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway.
    Jin G; Ma M; Yang C; Zhen L; Feng M
    Thorac Cancer; 2023 Aug; 14(24):2493-2503. PubMed ID: 37423604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer.
    Sun S; Zhou W; Li X; Peng F; Yan M; Zhan Y; An F; Li X; Liu Y; Liu Q; Piao H
    Cancer Commun (Lond); 2021 Sep; 41(9):851-866. PubMed ID: 34251762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin α2 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity.
    Jing H; Meng M; Ye M; Liu S; Cao X; Li K; Liu Y; Zhang J; Wu Y
    J Investig Med; 2024 Jan; 72(1):57-66. PubMed ID: 37804164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma.
    Zhu J; Li Y; Lv X
    Immunogenetics; 2023 Feb; 75(1):17-25. PubMed ID: 36056935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression.
    Li B; Wang B
    Immunol Invest; 2022 Oct; 51(7):1921-1937. PubMed ID: 35852892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles.
    Jing H; Cao X; Li K; Liu Y; Meng M; Liu S; Ye M; Zhang J; Wu Y
    Scand J Immunol; 2024 Sep; 100(3):e13393. PubMed ID: 38922971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
    Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
    Front Oncol; 2022; 12():904969. PubMed ID: 35978822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of M2 type macrophage-derived extracellular vesicles regulating PD-L1 expression via the MISP/IQGAP1 axis in hepatocellular carcinoma immunotherapy resistance.
    Wang X; Ye X; Chen Y; Lin J
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110848. PubMed ID: 37633233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAX transcriptionally enhances PD-L1 to inhibit CD8+ T cell-mediated killing of lung adenocarcinoma cells.
    Huang D; Wang X; Qian Y; Wu J; Chen B; Zhang D; Dong F; Li Y
    Cell Immunol; 2023 Apr; 386():104706. PubMed ID: 36931054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma.
    Battaglia AM; Sacco A; Aversa I; Santamaria G; Palmieri C; Botta C; De Stefano R; Bitetto M; Petriaggi L; Giorgio E; Faniello CM; Costanzo F; Biamonte F
    Front Cell Dev Biol; 2023; 11():1208485. PubMed ID: 37377735
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
    Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
    Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
    Tian P; Wei JX; Li J; Ren JK; Yang JJ
    Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
    Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
    PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer.
    Luo Z; Xu J; Xu D; Xu J; Zhou R; Deng K; Chen Z; Zou F; Yao L; Hu Y
    Immun Inflamm Dis; 2023 Jul; 11(7):e851. PubMed ID: 37506147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor NFYA inhibits ferroptosis in lung adenocarcinoma cells by regulating PEBP1.
    Chen F; Xu T; Jin N; Li D; Ying Y; Wang C
    Mutat Res; 2024 Jul; 829():111873. PubMed ID: 38996537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.